JF
ANAB icon

Jump Financial’s AnaptysBio ANAB Stock Holding History

Jump Financial’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,900
Closed -$216K – 2002
2026
Q1 		$216K Sell
3,900
-116,317
-97% -$6.26M ﹤0.01% 1630
2025
Q4 		$5.83M Buy
120,217
+38,140
+46% +$1.49M 0.07% 338
2025
Q3 		$2.51M Buy
+82,077
New +$1.88M 0.03% 657
2024
Q4 		– Sell
-39,032
Closed -$1.31M – 1616
2024
Q3 		$1.31M Buy
39,032
+3,332
+9% +$114K 0.03% 681
2024
Q2 		$895K Buy
+35,700
New +$831K 0.02% 867
2023
Q3 		– Sell
-29,260
Closed -$595K – 1817
2023
Q2 		$595K Buy
+29,260
New +$593K 0.02% 945
2023
Q1 		– Sell
-18,730
Closed -$580K – 1554
2022
Q4 		$580K Buy
18,730
+5,281
+39% +$149K 0.03% 715
2022
Q3 		$343K Sell
13,449
-1,976
-13% -$46.3K 0.01% 1074
2022
Q2 		$313K Buy
+15,425
New +$342K 0.01% 1040
2021
Q4 		– Sell
-11,900
Closed -$323K – 1354
2021
Q3 		$323K Buy
+11,900
New +$302K 0.02% 630

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Jump Financial's ANAB Position: Q2 2026 in Review

Jump Financial sold out of AnaptysBio (ANAB) in Q2 2026, closing a stake of 3,900 shares — an estimated $216K sold.

Jump Financial first reported a position in ANAB in Q3 2021 and held it in 10 quarters. The position peaked at $5.83M in Q4 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Jump Financial reported no remaining AnaptysBio position as of Q2 2026 after selling out during the quarter.
  • Jump Financial sold 3,900 AnaptysBio shares in Q2 2026, an estimated $216K.
  • Jump Financial first reported a position in AnaptysBio in Q3 2021 and held it in 10 quarters.
  • Jump Financial's AnaptysBio position peaked at $5.83M in Q4 2025.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.